Home > Insider Trading > Filing (0001209191-17-046039)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
873303	Sarepta Therapeutics Inc.	SRPT	Pharmaceutical Preparations (2834)	930797222

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1511034	Sandesh Mahatme	215 First Street, Suite 415 Cambridge MA 02142	Evp, Cfo & Cbo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-07-20	9,375	$13.71	41,736	No	4	M	Direct
Common Stock	Disposition	2017-07-20	9,375	$41.00	32,361	No	4	S	Direct
Common Stock	Acquisiton	2017-07-20	32,998	$13.90	65,359	No	4	M	Direct
Common Stock	Disposition	2017-07-20	32,998	$41.00	32,361	No	4	S	Direct
Common Stock	Acquisiton	2017-07-20	7,627	$23.85	39,988	No	4	M	Direct
Common Stock	Disposition	2017-07-20	7,627	$41.00	32,361	No	4	S	Direct
Common Stock	Acquisiton	2017-07-21	1,500	$23.85	33,861	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options (right to buy)	Disposition	2017-07-20	9,375	$13.71	9,375	$13.71
Common Stock	Non-Qualified Stock Options (right to buy)	Disposition	2017-07-20	32,998	$13.90	32,998	$13.90
Common Stock	Non-Qualified Stock Options (right to buy)	Disposition	2017-07-20	7,627	$23.85	7,627	$23.85
Common Stock	Incentive Stock Option (right to buy)	Disposition	2017-07-21	1,500	$23.85	1,500	$23.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
24,591	2017-02-28	2026-02-28	No	4	M	Direct
56,866	2016-02-27	2025-02-27	No	4	M	Direct
125,605	2013-11-05	2022-11-05	No	4	M	Direct
14,268	2017-02-28	2026-02-28	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 18, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 2, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.
25% of the option became exercisable on the first anniversary of the date of hire (11/05/2012) and 1/48th of the total granted option became exercisable on each monthly anniversary thereafter, such that the option became fully exercisable on the fourth anniversary of the date of hire.